187 related articles for article (PubMed ID: 20625431)
21. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
[TBL] [Abstract][Full Text] [Related]
22. Mutant prion protein D202N associated with familial prion disease is retained in the endoplasmic reticulum and forms 'curly' intracellular aggregates.
Gu Y; Verghese S; Bose S; Mohan M; Singh N
J Mol Neurosci; 2007; 32(1):90-6. PubMed ID: 17873292
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
[TBL] [Abstract][Full Text] [Related]
24. Clearance of variant Creutzfeldt-Jakob disease prions in vivo by the Hsp70 disaggregase system.
Thackray AM; Lam B; McNulty EE; Nalls AV; Mathiason CK; Magadi SS; Jackson WS; Andréoletti O; Marrero-Winkens C; Schätzl H; Bujdoso R
Brain; 2022 Sep; 145(9):3236-3249. PubMed ID: 35446941
[TBL] [Abstract][Full Text] [Related]
25. The prion-ZIP connection: From cousins to partners in iron uptake.
Singh N; Asthana A; Baksi S; Desai V; Haldar S; Hari S; Tripathi AK
Prion; 2015; 9(6):420-8. PubMed ID: 26689487
[TBL] [Abstract][Full Text] [Related]
26. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
27. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
28. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.
Schmitz M; Candelise N; Kanata E; Llorens F; Thüne K; Villar-Piqué A; da Silva Correia SM; Dafou D; Sklaviadis T; Appelhans D; Zerr I
Mol Neurobiol; 2020 Apr; 57(4):1863-1874. PubMed ID: 31848935
[TBL] [Abstract][Full Text] [Related]
29. Molecular interaction of TPPP with PrP antagonized the CytoPrP-induced disruption of microtubule structures and cytotoxicity.
Zhou RM; Jing YY; Guo Y; Gao C; Zhang BY; Chen C; Shi Q; Tian C; Wang ZY; Gong HS; Han J; Xu BL; Dong XP
PLoS One; 2011; 6(8):e23079. PubMed ID: 21857997
[TBL] [Abstract][Full Text] [Related]
30. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.
Hafner-Bratkovič I; Benčina M; Fitzgerald KA; Golenbock D; Jerala R
Cell Mol Life Sci; 2012 Dec; 69(24):4215-28. PubMed ID: 22926439
[TBL] [Abstract][Full Text] [Related]
31. Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport.
Singh A; Kong Q; Luo X; Petersen RB; Meyerson H; Singh N
PLoS One; 2009 Jul; 4(7):e6115. PubMed ID: 19568430
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.
Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N
Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871
[TBL] [Abstract][Full Text] [Related]
34. An astrocyte cell line that differentially propagates murine prions.
Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
[TBL] [Abstract][Full Text] [Related]
35. Increased iron-induced oxidative stress and toxicity in scrapie-infected neuroblastoma cells.
Fernaeus S; Land T
Neurosci Lett; 2005 Jul; 382(3):217-20. PubMed ID: 15925093
[TBL] [Abstract][Full Text] [Related]
36. Minimal change prion retinopathy: Morphometric comparison of retinal and brain prion deposits in Creutzfeldt-Jakob disease.
Goodwill VS; Dryden I; Choi J; De Lillo C; Soldau K; Llibre-Guerra J; Sanchez H; Sigurdson CJ; Lin JH
Exp Eye Res; 2022 Sep; 222():109172. PubMed ID: 35803332
[TBL] [Abstract][Full Text] [Related]
37. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
38. Cytosolic PrP can participate in prion-mediated toxicity.
Thackray AM; Zhang C; Arndt T; Bujdoso R
J Virol; 2014 Jul; 88(14):8129-38. PubMed ID: 24807727
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic characteristics of sporadic Japanese Creutzfeldt-Jakob disease classified according to prion protein gene polymorphism and prion protein type.
Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
Acta Neuropathol; 2006 Nov; 112(5):561-71. PubMed ID: 16847689
[TBL] [Abstract][Full Text] [Related]
40. Creutzfeldt-Jakob disease and scrapie prions.
Prusiner SB
Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
